Synthesis of new bridgehead substituted azabicyclo-[2.2.1]heptane and -[3.3.1]nonane derivatives as potent and selective α7 nicotinic ligands.
Slowinski
Franck
F
Sanofi-Aventis R&D, 1 Avenue Pierre Brossolette, 91385 Chilly-Mazarin Cedex, France. franck.slowinski@sanofi-aventis.com
Ben Ayad
Omar
O
Vache
Julien
J
Saady
Mourad
M
Leclerc
Odile
O
Lochead
Alistair
A